利用诊断性增强CT影像组学预测结直肠癌术后复发:一项双中心研究
本研究纳入两家法国大学医院2008年7月1日至2017年3月15日诊治的193例II期和III期结直肠腺癌患者,采用Bootstrapped ComBat harmonization校正双中心数据变异,基于增强CT影像组学构建预测无病生存的机器学习模型;经B-ComBat校正后模型性能系统性高于未校正原始数据,其中多变量回归模型结合术后化疗与两个形状特征在95%敏感度下BAcc为0.78、MCC为0.6,无病生存分层显著(p=0.00021)。
要点
- 基于增强CT的影像组学模型可在双中心队列中训练和验证,对II期和III期结直肠癌术后复发具有良好预测性能。
- 经B-ComBat校正后,平衡模型和95%敏感度模型的性能均系统性高于未校正原始数据。
- 多变量回归模型结合术后化疗与形状特征(紧密度、最短轴长度)在95%敏感度下BAcc为0.78、MCC为0.6,无病生存分层p=0.00021。
核心结论
- 基于增强CT的影像组学模型可在双中心队列中训练和验证,对II期和III期结直肠癌患者的复发具有良好预测性能。
研究设计与样本
- 双中心研究,纳入两家法国大学医院2008年7月1日至2017年3月15日诊治的193例II期和III期结直肠腺癌患者,采用Bootstrapped ComBat(B-ComBat)校正双中心数据变异,基于增强CT影像组学构建预测无病生存的模型,使用多变量回归(经LASSO特征选择后10折交叉验证)、随机森林和支持向量机三种机器学习方法。
关键影像表现/征象
- 基于增强CT提取的影像组学形状描述符包括紧密度和最短轴长度。
- 多变量回归模型结合临床变量(术后化疗)与两个影像组学形状描述符(紧密度和最短轴长度)。
诊断标准与关键数值
- 平衡模型和95%敏感度模型在B-ComBat校正后的性能均系统性高于未校正原始数据。
- 多变量回归模型在95%敏感度下BAcc为0.78、MCC为0.6。
- 多变量回归模型的无病生存分层显著(p=0.00021),未校正原始数据分层p=0.17。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the value of contrast-enhanced (CE) diagnostic CT scans characterized through radiomics as predictors of recurrence for patients with stage II and III colorectal cancer in a two-center context.
MATERIALS AND METHODS: This study included 193 patients diagnosed with stage II and III colorectal adenocarcinoma from 1 July 2008 to 15 March 2017 in two different French University Hospitals. To compensate for the variability in two-center data, a statistical harmonization method Bootstrapped ComBat (B-ComBat) was used. Models predicting disease-free survival (DFS) were built using 3 different machine learning (ML): (1) multivariate regression (MR) with 10-fold cross-validation after feature selection based on least absolute shrinkage and selection operator (LASSO), (2) random forest (RF), and (3) support vector machine (SVM), both with embedded feature selection.
RESULTS: The performance for both balanced and 95% sensitivity models was systematically higher after our proposed B-ComBat harmonization compared to the use of the original untransformed data. The most clinically relevant performance was achieved by the multivariate regression model combining a clinical variable (postoperative chemotherapy) with two radiomics shape descriptors (compactness and least axis length) with a BAcc of 0.78 and an MCC of 0.6 associated with a required sensitivity of 95%. The resulting stratification in terms of DFS was significant (p = 0.00021), especially compared to the use of unharmonized original data (p = 0.17).
CONCLUSIONS: Radiomics models derived from contrast-enhanced CT could be trained and validated in a two-center cohort with a good predictive performance of recurrence in stage II et III colorectal cancer patients.
KEY POINTS: • Adjuvant therapy decision in colorectal cancer can be a challenge in medical oncology. • Radiomics models, derived from diagnostic CT, trained and validated in a two-center cohort, could predict recurrence in stage II and III colorectal cancer patients. • Identifying patients with a low risk of recurrence, these models could facilitate treatment optimization and avoid unnecessary treatment.
引用
- Badic B, Da-Ano R, Poirot K, et al. Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: a two-center study. Eur Radiol. 2021. PMID: 34170367. doi:10.1007/s00330-021-08104-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。